form 8k
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
JUNE 28, 2002
ASTRO-MED, INC
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
COMMISSION FILE NUMBER 0-13200
RHODE ISLAND 05-0318215
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION
INCORPORATION OR ORGANIZATION) NUMBER)
600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
(401-828-4000)
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On June 28, 2002, acting upon the recommendation of its Audit Committee, the Board of Directors of Astro-Med,
Inc. (the Company) dismissed the Company's independent auditors, Arthur Andersen LLP (AA). The Company is in the
process of interviewing qualified independent auditors to replace AA and anticipates that it will have reached
agreement with a nationally recognized public accounting firm shortly.
During the two most recent fiscal years of the Company ended January 31, 2002 and 2001, and the subsequent
interim period through June 28, 2002, there were no disagreements between the Company and AA on any matters of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to AA's satisfaction, would have caused AA to make reference to the subject matter
of the disagreement in connection with its reports; and there were no reportable events described under Item 304
(a) (1) (v) of Regulation S-K.
The audit reports of AA on the consolidated financial statements of the Company as of and for the fiscal years
ended January 31, 2002 and 2001 did not contain any adverse opinion or disclaimers of opinion, nor were they
qualified or modified as to uncertainty, audit scope or accounting principles. A letter from AA attached hereto
as Exhibit 16.1, indicating its concurrence with disclosures in this and the preceding paragraph.
During the two most recent fiscal years of the Company ended January 31, 2002 and 2001 and the subsequent interim
period through June 28, 2002, the Company did not consult any other firms regarding any of the matters or events
set forth in Item 304 (a) (2) (i) and (ii) of Regulation S-K.
ITEM 7. FINANCIAL STATEMENTS, PROFORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit 16.1 - Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated June 28,
2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report
to be signed on their behalf by the undersigned thereunto duly authorized.
DATE: JUNE 28, 2002 ASTRO-MED, INC.
By: /s/ Joseph P. O'Connell
Vice President and Treasurer Chief
Financial Officer
EXHIBIT INDEX
EXHIBIT DESCRIPTION
16.1 Letter from Arthur Andersen LLP to the Securities and Exchange Commission
Dated June 28, 2002.
EXHIBIT 16.1
June 28, 2002
Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Dear Sir or Madam:
The representations made in this letter are based solely on discussions with and representations from the
engagement partner and manager on the audits of the financial statements of this registrant for the two most
recent fiscal years. Those individuals are no longer with Arthur Andersen LLP. We have read the first three
paragraphs of Item 4 included in the Form 8-K dated June 28, 2002, of Astro-Med, Inc. to be filed with the
Securities and Exchange Commission and have found no basis for disagreement with the statements contained
therein.
Very truly yours,
/s/ Arthur Andersen LLP
cc: Mr. Joseph P. O'Connell, CFO, Astro-Med, Inc.